RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 95 filers reported holding RELAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,288,203 | -30.9% | 153,177 | +3.2% | 0.00% | -50.0% |
| Q2 2023 | $1,863,979 | +83374.2% | 148,406 | +9.5% | 0.00% | -33.3% |
| Q1 2023 | $2,233 | +16.0% | 135,560 | +5.2% | 0.00% | 0.0% |
| Q4 2022 | $1,925 | -99.9% | 128,864 | +8.7% | 0.00% | -25.0% |
| Q3 2022 | $2,652,000 | +43.4% | 118,559 | +7.4% | 0.00% | +33.3% |
| Q2 2022 | $1,850,000 | -18.1% | 110,437 | +46.4% | 0.00% | 0.0% |
| Q1 2022 | $2,258,000 | +5.0% | 75,438 | +7.8% | 0.00% | 0.0% |
| Q4 2021 | $2,150,000 | +10.4% | 70,001 | +13.4% | 0.00% | 0.0% |
| Q3 2021 | $1,947,000 | -9.6% | 61,741 | +4.9% | 0.00% | 0.0% |
| Q2 2021 | $2,154,000 | +23.9% | 58,865 | +17.1% | 0.00% | +50.0% |
| Q1 2021 | $1,738,000 | +3.6% | 50,282 | +24.5% | 0.00% | 0.0% |
| Q4 2020 | $1,678,000 | +7.6% | 40,380 | +10.3% | 0.00% | 0.0% |
| Q3 2020 | $1,559,000 | – | 36,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |